Duncan, Canada

Mark Leung

This inventor holds 1 USPTO granted patent. Top assignee: Zidan Medical Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Leung. Retrieved from https://idiyas.com/inventor/mark-leung-jjf59drg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Leung and His Lung-Tumor Treatment Patent.

Introduction

Mark Leung is an inventor associated with Duncan, California, and Zidan Medical Inc. His work includes a patented approach for treating lung tumors using a catheter, heated conductive saline, and electrical measurements to guide treatment.

Latest Patents

The provided information lists 1 patent for Mark Leung: “Systems, Devices and Methods for Treating Lung Tumor.” The method advances a catheter through a natural airway and positions its distal portion near a target region in the lung. It then injects conductive hypertonic saline containing at least 5% sodium chloride by weight per volume and delivers energy to heat the solution and ablate the target tissue. During energy delivery, the method senses the target region’s electrical impedance or conductivity and adjusts the saline injection rate or bolus based on those measurements.

Career Highlights

Leung’s listed patent describes a treatment technique that combines catheter-based delivery, heated saline ablation, and electrical feedback. The information provided identifies Zidan Medical Inc. as his company.

Collaborations

Dorin Panescu and Shashank Raina are identified as Leung’s coworkers. Their names are provided as professional associations, without further details about their roles or contributions to the patent.

Conclusion

Mark Leung’s listed invention presents a catheter-based lung-tumor treatment that uses heated conductive saline and electrical feedback to guide ablation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…